CTN
NIDA-CTN-0068
Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT-2)
Madhukar H. Trivedi, M.D.
Oct 07, 2022
CTN
NIDA-CTN-0054
Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT)
Walter Ling, M.D.
Oct 09, 2020
DTMC
NIDA-CPU-0010
Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine
Louis Cantilena, Jr., M.D, Ph.D.
Jun 03, 2020
DTMC
NIDA-CTO-0011
Double-Blind, Placebo-Controlled, Dose Response Trial Of Ondansetron For The Treatment Of Methamphetamine Dependence
Bankole Johnson, DSc., M.D., Ph.D.
Jan 15, 2019
DTMC
NIDA-CTO-0012
Phase 2, Double-Blind, Placebo-Controlled Trial Of Tiagabine For The Treatment Of Cocaine Dependence
Eugene Somoza, M.D.
Jan 15, 2019
DTMC
NIDA-MDS-0002
Assessment of Interactions Between Methamphetamine and Aripiprazole
Thomas F. Newton, M.D.
May 07, 2018
DTMC
NIDA-CTO-0010
Assessment of Potential Interactions Between Methamphetamine and Bupropion
Thomas F. Newton, M.D.
May 07, 2018
DTMC
NIDA-CTO-0008
Phase 2, Double-Blind Placebo-Controlled Trial Of Bupropion for the Treatment of Methamphetamine Dependence
Richard Rawson, Ph.D.
May 07, 2018
DTMC
NIDA-CSP-1022
Phase 2, Double-Blind, Placebo-Controlled Trial Of Selegiline Transdermal System (STS) As An Aid For Smoking Cessation
Elbert D. Glover, PhD, FASHA, FAAHB, FRIPH
May 07, 2018
DTMC
NIDA-CSP-1021
Double-Blind, Placebo-Controlled Multi-Center Trial Of Baclofen For The Treatment Of Cocaine Dependence
Liza Gorgon, M.A.
May 07, 2018
DTMC
NIDA-CSP-1019
Double-Blind, Placebo-Controlled Trial Of Selegiline Transdermal System For The Treatment Of Cocaine Dependence
Ahmed Elkashef, M.D. , Paul J. Fudala, Ph.D.
May 07, 2018
DTMC
NIDA-MDS-0003
Phase I, Double-Blind, Placebo-Controlled Assessment Of Potential Interactions Between Intravenous Cocaine And Ethanol And Oral Disulfiram
John D. Roache, Ph.D.
Dec 21, 2017
DTMC
NIDA-CPU-0008
Double-Blind, Placebo-Controlled Assessment of Interactions Between Intravenous Methamphetamine and Modafinil
Reese Jones, M.D.
Dec 21, 2017
DTMC
NIDA-CTO-0007
Phase 2, Double-Blind, Placebo-Controlled Trial Of Cabergoline For The Treatment Of Cocaine Dependence
Steven Shoptaw, Ph.D. , Thomas F. Newton, M.D.
Dec 21, 2017
DTMC
NIDA-CPU-0005
Double-blind, placebo-controlled, safety and pharmacology study with 75 mg dosage of GBR 12909 in cocaine experienced African American Volunteers.
Louis Cantilena, Jr., M.D, Ph.D.
May 23, 2017
DTMC
NIDA-CPU-0004
Study of Interactions Between GBR 12909 and Cocaine
Kathryn Cunningham, Ph.D. , John Grabowski, Ph.D.
May 23, 2017
DTMC
NIDA-CPU-0006
A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine
Reese Jones, M.D.
May 23, 2017
DTMC
NIDA-CPU-0003
Phase I, Double-Blind, Placebo-Controlled Dose Escalating Assessment of Potential Interactions Between Intravenous Cocaine and RPR 102681
Louis Cantilena, Jr., M.D, Ph.D.
May 23, 2017
DTMC
NIDA-CPU-0002
Double-Blind, Placebo-Controlled, Dose Escalating, Safety and Pharmacology Study With Three Dosages of GBR 12909 in Cocaine Experienced Volunteers
Louis Cantilena, Jr., M.D, Ph.D.
May 23, 2017
DTMC
NIDA-CTO-0006
Cocaine-Metyrapone Interaction Study
Bonita Singal, M.D. , T. John Winhusen, Ph.D.
Aug 01, 2016
DTMC
NIDA-CTO-0005
Double-Blind, Placebo-Controlled Trial Of Ondansetron For The Treatment Of Cocaine Dependence
John D. Roache, Ph.D.
Aug 01, 2016
DTMC
NIDA-CTO-0004
Assessment Of Potential Interactions Between Intravenous Methamphetamine And Oral Selegiline
Thomas F. Newton, M.D.
Aug 01, 2016
DTMC
NIDA-CTO-0003
Assessment Of Potential Interactions Between Intravenous Cocaine And Tolcapone
Thomas F. Newton, M.D.
Aug 01, 2016
DTMC
NIDA-MDS-0007
Phase 2, Double-Blind, Placebo-Controlled Trial Of Bupropion For Methamphetamine Dependence
Ann Anderson, M.D.
Dec 04, 2014
DTMC
NIDA-MDS-0004
Phase 2, Double-Blind, Placebo-Controlled Trial Of Modafinil For The Treatment Of Cocaine Dependence
Domenic Ciraulo, M.D.
Sep 02, 2015
DTMC
NIDA-CTO-0001
Phase 2, Double-Blind, Placebo-Controlled Trial Of Reserpine For The Treatment Of Cocaine Dependence
Eugene Somoza, M.D.
Dec 04, 2014
CTN
NIDA-CTN-0052
A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence (BRAC)
T. John Winhusen, Ph.D.
May 14, 2014
CTN
NIDA-CTN-0046
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
T. John Winhusen, Ph.D. , Eugene Somoza, M.D.
Nov 19, 2013
CTN
NIDA-CTN-0037
Stimulant Reduction Intervention using Dosed Exercise (STRIDE)
Madhukar H. Trivedi, M.D.
Apr 24, 2015
CTN
NIDA-CTN-0031A
An Evaluation of Neurocognitive Function, Oxidative Damage, and Their Association With Treatment Outcomes in Methamphetamine and Cocaine Abusers
T. John Winhusen, Ph.D. , Eugene Somoza, M.D.
Nov 26, 2013
CTN
NIDA-CTN-0031
Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement
Dennis Donovan, Ph.D. , Dennis Daley, Ph.D.
Feb 06, 2012
DTMC
NIDA-CSP-1026
Phase 2, Double-Blind, Placebo-Controlled Trial Of Modafinil For Methamphetamine Dependence
Ahmed Elkashef, M.D.
Sep 02, 2015
DTMC
NIDA-CSP-1025
Phase 2, Double-Blind, Placebo-Controlled Trial Of Topiramate For The Treatment Of Methamphetamine Dependence
Bankole Johnson, DSc., M.D., Ph.D.
Sep 02, 2015
DTMC
NIDA-CPU-0016
Double-Blind, Placebo-Controlled Assessment Of Potential Interactions Between Intravenous Methamphetamine And Osmotic-Release Methylphenidate (Oros-Mph)
Eugene Somoza, M.D.
Dec 04, 2014